ESTIMATING THE TIME OF PRODUCTIVITY LOST OF PATIENTS WITH CANCER AND MUSCULAR-SKELETAL DISEASES IN SLOVAKIA

Author(s)

Lenka Petrova, Mgr, Student PhD1, Viliam Foltan, prof, Head of Department1, Rastislav Binder, PhD, Researcher1, Jan Bielik, MD, PhD, AssProf, Dean of Faculty21Comenius University, Bratislava, Slovak Republic; 2 Trencin University, Trencin, Slovak Republic

OBJECTIVES: Cancer and muscular-skeletal diseases are embraced in the group of diseases requesting a high number of the health care resources, imposing a substantial economic burden to patient, health-social insurance and to society in Slovakia. The objective of the study was to estimate the number of productivity lost days and calculate the indirect costs associated with the consumption of the health-social insurance system. METHODS: With the use of a national database of patients we developed a retrospective analysis with the identification of the number of productivity lost days due to cancer and muscular-skeletal disorders during the period of the year 2007. By the comparison-analysis we analyzed the differences between the longest and the shortest period of productivity lost focusing on the cancer and muscular-skeletal and we calculated the health-social insurance costs. RESULTS: Cancer shows the average number of productivity lost in males 104.2 and 74.3 in females, the longest period of days of productivity lost represent 151.4 days in males age 60 and more and 119.7 days in females age 55-59. Muscular-skeletal diseases showed these results: in average 41.2 days in males and 50.3 days in females. The longest period of days of productivity lost, is 64.4 days in males age 55-59, and 76.9 days in females age 60. One day of productivity lost costs the health-social insurance system in average €140.78 per patient, in this case, days of lost productivity due to cancer represent the average costs of health insurance €25.129,23 and due to the muscular-skeletal €12.881,37; in both gender together. This number represents indirect costs. CONCLUSIONS: This retrospective analysis highlighted the importance to pay attention to indirect cost during the overall management of decision-making process for the cancer and muscular-skeletal diseases due to their high supplies of health resources.

Conference/Value in Health Info

2009-05, ISPOR 2009, Orlando, FL, USA

Value in Health, Vol. 12, No. 3 (May 2009)

Code

PCN96

Topic

Economic Evaluation

Topic Subcategory

Work & Home Productivity - Indirect Costs

Disease

Musculoskeletal Disorders, Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×